Stocksigma LogoStocksigma Logo

Senores Pharmaceuticals Subsidiary Successfully Completes USFDA Inspection at Vadodara Facility

The USFDA successfully completed an inspection at the Vadodara manufacturing facility of Apnar Pharma Private Limited, a subsidiary of Senores

Senores Pharmaceuticals Subsidiary Successfully Completes USFDA Inspection at Vadodara Facility

Senores Pharmaceuticals Ltd 路 Others (Uncategorized) 路 11 Sept 2026, 7:12 pm

Senores Pharmaceuticals Subsidiary Successfully Completes USFDA Inspection at Vadodara Facility The USFDA successfully completed an inspection at the Vadodara manufacturing facility of Apnar Pharma Private Limited, a subsidiary of Senores Pharmaceuticals Limited. Conducted from 7th Sep'26 to 11th Sep'26, the audit concluded with zero GMP-related observations and only one minor procedural observation. The subsidiary will submit its formal response within the stipulated timeframe, posing minimal regulatory risk to ongoing manufacturing operations.

Original exchange filing (PDF)

More announcements from Senores Pharmaceuticals Ltd

All Senores Pharmaceuticals Ltd announcements